95 related articles for article (PubMed ID: 19276405)
1. Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?
Morrison JL; Orgeig S
Reprod Sci; 2009 Jun; 16(6):527-38. PubMed ID: 19276405
[TBL] [Abstract][Full Text] [Related]
2. Antenatal glucocorticoids reduce growth in appropriately grown and growth-restricted ovine fetuses in a sex-specific manner.
Miller SL; Sutherland AE; Supramaniam VG; Walker DW; Jenkin G; Wallace EM
Reprod Fertil Dev; 2012; 24(5):753-8. PubMed ID: 22697125
[TBL] [Abstract][Full Text] [Related]
3. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
Kinalski M; Sledziewski A; Kretowski A
Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
[TBL] [Abstract][Full Text] [Related]
4. Mending a growth-restricted fetal heart: should we use glucocorticoids?
Hodges RJ; Wallace EM
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2149-53. PubMed ID: 22764774
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus.
Miller SL; Supramaniam VG; Jenkin G; Walker DW; Wallace EM
Am J Obstet Gynecol; 2009 Dec; 201(6):613.e1-8. PubMed ID: 19766978
[TBL] [Abstract][Full Text] [Related]
6. Is antenatal steroid treatment effective in preterm IUGR fetuses?
Torrance HL; Derks JB; Scherjon SA; Wijnberger LD; Visser GH
Acta Obstet Gynecol Scand; 2009; 88(10):1068-73. PubMed ID: 19670049
[TBL] [Abstract][Full Text] [Related]
7. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
Sauerwald A; Rath W
Z Geburtshilfe Neonatol; 2000; 204(6):203-9. PubMed ID: 11199148
[TBL] [Abstract][Full Text] [Related]
8. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study.
van Stralen G; van der Bos J; Lopriore E; Te Pas AB; Bloemenkamp KW; Walther FJ; Scherjon S
Early Hum Dev; 2009 Apr; 85(4):253-7. PubMed ID: 19028421
[TBL] [Abstract][Full Text] [Related]
9. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?
Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S
J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338
[TBL] [Abstract][Full Text] [Related]
10. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
[TBL] [Abstract][Full Text] [Related]
11. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK
N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465
[TBL] [Abstract][Full Text] [Related]
12. Antenatal glucocorticoids and renal function after birth.
Jahnukainen T; Chen M; Berg U; Celsi G
Semin Neonatol; 2001 Aug; 6(4):351-5. PubMed ID: 11972436
[TBL] [Abstract][Full Text] [Related]
13. Effect of corticosteroids for fetal maturation on perinatal outcomes.
NIH Consens Statement; 1994 Feb 28-Mar 2; 12(2):1-24. PubMed ID: 7728157
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of selected methods for intrauterine stimulation of fetal pulmonary maturation].
Sledziewski A; Kinalski M; Kretowski A
Przegl Lek; 2000; 57(3):171-7. PubMed ID: 10909290
[TBL] [Abstract][Full Text] [Related]
15. Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery--correlation with short-term outcome.
Schwarze A; Gembruch U; Krapp M; Katalinic A; Germer U; Axt-Fliedner R
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):573-9. PubMed ID: 15912468
[TBL] [Abstract][Full Text] [Related]
16. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation.
Smith LM; Qureshi N; Chao CR
J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829
[TBL] [Abstract][Full Text] [Related]
17. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus.
Ferrazzi E; Bozzo M; Rigano S; Bellotti M; Morabito A; Pardi G; Battaglia FC; Galan HL
Ultrasound Obstet Gynecol; 2002 Feb; 19(2):140-6. PubMed ID: 11876805
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up.
de Vries WB; Karemaker R; Mooy NF; Strengers JL; Kemperman H; Baerts W; Veen S; Visser GH; Heijnen CJ; van Bel F
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):738-44. PubMed ID: 18678806
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of prenatal glucocorticoid treatment in the preterm infant.
Rubaltelli FF; Chiti G; Dani C
Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():35-8. PubMed ID: 10021715
[TBL] [Abstract][Full Text] [Related]
20. The effect of glucocorticoid therapy in preventing early neonatal complications in preterm delivery.
Madarek EO; Najati N
J Perinat Med; 2003; 31(5):441-3. PubMed ID: 14601269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
